Overview

The Combination of Atorvastatin, Acetylcysteine and Danazol as the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia

Status:
Not yet recruiting

Trial end date:
2023-01-01

Target enrollment:

Participant gender:

Summary

Single-arm, open-lable, multicentre study to compare the efficacy and safety of atorvastatin, acetylcysteine plus danazol with danazol monotherapy in patients with corticosteroidresistant/relapsed ITP.

Phase:

Phase 1/Phase 2

Details

Lead Sponsor:

Peking University People's Hospital

Treatments:

Acetylcysteine
Atorvastatin
Atorvastatin Calcium
Danazol
N-monoacetylcystine